T and B immunodepression during 7,12-dimethylbenz(alpha) anthracene (DMBA) carcinogenesis in mice.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000941:Antigens; D001402:B-Lymphocytes / Q000276:immunology*; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D007165:Immunosuppression Therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology*; D011205:Povidone; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000378:metabolism
D000941:Antigens; D001551:Benz(a)Anthracenes; D015127:9,10-Dimethyl-1,2-benzanthracene; D011205:Povidone; D013936:Thymidine